M1A.269 Drug-induced chronic gout, unspecified knee

Name of the Condition

• Drug-Induced Chronic Gout, Unspecified Knee

Summary

Drug-induced chronic gout, unspecified knee is a form of arthritis affecting the knee joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and may involve the formation of tophi (urate crystal deposits) in advanced stages.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the knee joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense knee pain, often with swelling and redness
• Persistent warmth and tenderness in the affected knee
• Formation of tophi (hard, painless lumps) around the knee joint
• Stiffness and limited range of motion in the knee
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests may show elevated uric acid levels, while joint fluid analysis can identify urate crystals. Imaging such as X-rays or ultrasound may reveal joint damage or tophi. The unspecified knee designation indicates the affected side is not documented.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs (e.g., NSAIDs or colchicine). In severe cases, corticosteroids or biologics may be used. Lifestyle modifications, such as dietary changes, are often recommended.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels and adjust treatment. Untreated or poorly managed cases may lead to progressive joint damage and disability.

Complications

• Chronic joint damage and deformity
• Recurrent flare-ups
• Formation of tophi, which may ulcerate or become infected
• Kidney stones or renal impairment due to uric acid accumulation

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood)
• Stay hydrated to support uric acid excretion
• Limit alcohol consumption, especially beer
• Engage in regular, low-impact exercise to support joint health

When to Seek Professional Help

Seek medical attention if you experience sudden, severe knee pain, swelling, or redness, or if symptoms persist despite home care. Prompt evaluation is important to prevent long-term joint damage.

Tips for Medical Coders

Document the unspecified knee designation when the affected side is not specified. Ensure the code aligns with clinical documentation of drug-induced chronic gout affecting the knee joint. Verify that the underlying cause (medication use) is clearly documented to support accurate coding.